Improve the results of phase II trials of thromboprophylaxis with the new oral anticoagulant drugs

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Thrombosis and haemostasis 2010-12, Vol.104 (6), p.1083-1084
Hauptverfasser:	Zufferey, Paul Jacques, Samama, Charles Marc, Rosencher, Nadia
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Anticoagulants - administration & dosage Anticoagulants - adverse effects Arthroplasty, Replacement, Knee - adverse effects Clinical Trials, Phase II as Topic Dose-Response Relationship, Drug Editorial Focus Elective Surgical Procedures Enoxaparin - administration & dosage Evidence-Based Medicine Factor Xa Inhibitors Hemorrhage - chemically induced Humans Pulmonary Embolism - blood Pulmonary Embolism - etiology Pulmonary Embolism - prevention & control Pyrimidinones - administration & dosage Risk Assessment Risk Factors Sulfones - administration & dosage Time Factors Venous Thromboembolism - blood Venous Thromboembolism - etiology Venous Thromboembolism - prevention & control Venous Thrombosis - blood Venous Thrombosis - etiology Venous Thrombosis - prevention & control
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!